Showing results (2131-2140 of 3,641) with videos related to
Sort By:
Pageof 365
Breast (Edinburgh, Scotland)|May 3, 2008
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studiesAlessandra Fabi, Giulio Metro, Gianluigi Ferretti, et al.Breast (Edinburgh, Scotland)|October 9, 2009
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer GroupFredrika Killander, Harald Anderson, Stefan Rydén, et al.Breast (Edinburgh, Scotland)|February 8, 2014
Disparities in female breast cancer mortality rates between urban centers and rural areas of Brazil: ecological time-series studyCarolina M R Gonzaga, Ruffo Freitas-Junior, Marta R Souza, et al.Breast (Edinburgh, Scotland)|January 24, 2025
Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiativeJan Henkel, Andreas Laner, Melanie Locher, et al.Breast (Edinburgh, Scotland)|January 25, 2025
Therapeutic strategies for fungating and ulcerating breast cancers: A systematic review and narrative synthesisValentina Zagardo, Mandara Harikar, Gianluca FeriniBreast (Edinburgh, Scotland)|January 18, 2025
Personalized treatment strategies for breast adenoid cystic carcinoma: A machine learning approachSakhr Alshwayyat, Mahmoud Bashar Abu Al Hawa, Mustafa Alshwayyat, et al.Breast (Edinburgh, Scotland)|January 18, 2025
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancerPaola Zagami, Angela Esposito, Beatrice Taurelli Salimbeni, et al.Breast (Edinburgh, Scotland)|January 8, 2025
Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world settingErik Olsson, Henrik Lindman, Evangelos Digkas, et al.Breast (Edinburgh, Scotland)|January 3, 2025
Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohortBryan F Vaca-Cartagena, Ana S Ferrigno Guajardo, Hatem A Azim, et al.Breast (Edinburgh, Scotland)|January 4, 2025
Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim DatabaseKeiko Miyazato, Hiroshi Ohtsu, Akihiko Shimomura, et al.Pageof 365